Cellebrite director reports initial share and RSU holdings

Cellebrite DI Ltd. director Yonatan Domnitz filed an initial ownership report showing his equity position in the company.

Rhea-AI Filing Summary

Cellebrite DI Ltd. director Yonatan Domnitz filed an initial ownership report showing his equity position in the company. The filing lists 10,601 restricted stock units, each representing a contingent right to receive one ordinary share, vesting on September 17, 2026.

In addition, he holds 60,795 ordinary shares directly after the reported positions. The restricted stock units have an exercise price of $0.0000, indicating they are granted as equity compensation rather than purchased in the market. This Form 3 does not reflect new open-market buying or selling, but establishes his starting ownership as an insider.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Domnitz Yonatan

Role Director

Type	Security	Shares	Price	Value
holding	Restricted Stock Units	--	--	--
holding	Ordinary Shares	--	--	--

Holdings After Transaction: Restricted Stock Units — 10,601 contracts (Direct); Ordinary Shares — 60,795 shares (Direct)

Footnotes (2)

1. F1. The restricted stock units vest on September 17, 2026.
2. F2. Each restricted stock unit represents a contingent right to receive one ordinary share.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider holdings did Yonatan Domnitz report in Cellebrite (CLBT) Form 3?

Yonatan Domnitz reported 60,795 ordinary shares and 10,601 restricted stock units in Cellebrite. The RSUs convert into ordinary shares on vesting, giving him meaningful equity exposure that aligns his interests with existing shareholders over time.

When do Yonatan Domnitz’s restricted stock units in Cellebrite (CLBT) vest?

The restricted stock units vest on September 17, 2026. This future vesting date means the equity award is designed to retain and incentivize Domnitz over the medium term, contingent on continued service or other plan conditions specified by the company.

How many restricted stock units does Yonatan Domnitz hold in Cellebrite (CLBT)?

He holds 10,601 restricted stock units, each corresponding to one ordinary share. Once they vest on September 17, 2026, and settlement conditions are met, these units can increase his ordinary share ownership without requiring cash payment at exercise.

Does the Cellebrite (CLBT) Form 3 show any insider share purchases or sales?

The Form 3 records holdings only and does not show explicit purchases or sales. It establishes Domnitz’s starting position as a director, listing his existing ordinary shares and unvested restricted stock units rather than reporting a new market transaction.

What is the conversion rate of Yonatan Domnitz’s RSUs into Cellebrite (CLBT) ordinary shares?

Each restricted stock unit represents a contingent right to receive one ordinary share. This one-for-one conversion simplifies understanding the potential future increase in his share ownership when the 10,601 units vest on September 17, 2026, subject to applicable conditions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/18/2026 - 03:17 PM Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Domnitz Yonatan

(Last) (First) (Middle)

94 SHLOMO SHMELZER ROAD

(Street)

PETAH TIKVA 4970602

(City) (State) (Zip)

ISRAEL

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
Cellebrite DI Ltd. [ CLBT ]

3a. Foreign Trading Symbol
[9W9]

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares	60,795	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	(1)	Ordinary Shares	10,601(2)	(2)	D

Explanation of Responses:

1. The restricted stock units vest on September 17, 2026.

2. Each restricted stock unit represents a contingent right to receive one ordinary share.

	/s/ Yonatan Domnitz	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)